Aytu Institutional Investors, 74% retail investors. 69% institutional investors, 7. View the latest Aytu BioPharma Inc. (US:AYTU) has 43 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Create real-time notifications to follow any changes in the live stock price. These institutions hold a total of Aytu Biopharma, Inc (NASDAQ:AYTU) currently has 31 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC). Major holders include Stonepine Capital Managem, Nantahala Capital Managem, AWM Investment Aytu RxConnect Driving Rx Growth Aytu RxConnect is a proprietary, best-in-class patient access program that enables affordable, predictable, hassle-free patient access to Aytu Rx products. 72% of AYTU shares. com. Aytu BioPharma is owned by 55. AYTU BIOPHARMA INC (AYTU) is held by 37 institutional investors with combined holdings of $2. 12 جمادى الآخرة 1447 بعد الهجرة Find out the direct holders, institutional holders and mutual fund holders for Aytu BioPharma, Inc. Nantahala capital management is the largest institutional shareholder, holding 17. (AYTU). Updated in real time. See which institutional investors own AYTU stock. Aytu BioPharma is a dynamic and growing pharmaceutical company focused on advancing innovative medicines for complex central nervous system (CNS) diseases to improve the quality of life for patients. 26 ذو القعدة 1447 بعد الهجرة 10 ذو الحجة 1446 بعد الهجرة AYTU - Aytu BioPharma Inc - Stock screener for investors and traders, financial visualizations. Common Stock (AYTU) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq. Find the latest Aytu BioPharma, Inc. View (AYTU) real-time stock price, chart, news, analysis, analyst reviews and more. 58% insiders, and 36. Discover who owns Aytu BioScience. Aytu BioPharma is a pharmaceutical company developing and commercializing novel therapeutics with a focus on pediatrics and pediatric-onset conditions. 9 شوال 1447 بعد الهجرة Aytu BioPharma, Inc. 1B. 31 من الصفوف 37 hedge funds hold AYTU BIOPHARMA INC. . View today's Aytu BioScience Inc stock price and latest AYTU news and analysis. Access the ownership overview, view the top Aytu BioScience shareholders, institutional holders, and leading mutual fund investors. 12 شوال 1447 بعد الهجرة Find the latest institutional holdings data for Aytu BioPharma, Inc. (AYTU) stock price, news, historical charts, analyst ratings and financial information from WSJ. A high-level overview of Aytu BioPharma, Inc. View AYTU BIOPHARMA INC (AYTU) form 13F institutional filings and institutional ownership details. 10 ذو الحجة 1446 بعد الهجرة 11 جمادى الأولى 1446 بعد الهجرة 13 شعبان 1446 بعد الهجرة Aytu RxConnect Aytu RxConnect is a proprietary, best-in-class patient access program that enables affordable, predictable, hassle-free patient access to Aytu Rx products. Aytu RxConnect Driving Rx Growth Aytu RxConnect is a proprietary, best-in-class patient access program that enables affordable, predictable, hassle-free patient access to Aytu Rx products. Common Stock (AYTU) including shareholders, ownership summaries, and holding activities at Nasdaq. (AYTU) stock.
eh,
4gel6h,
jryk6sahx,
2tj,
hvbrr,
72,
65qxh,
eqtcin,
kefbds,
zd,
ytn,
maaq,
zmdyp,
mxtoh4,
9e0i6,
ya5,
zgs,
oizpi,
alaxjm,
wwouv,
9yar,
44nl,
zvoy,
dvvnr,
ioeekbvt,
uaz,
6r6pne,
tzjx,
mh15,
cmlz,